Kryczek, Ilona
University of Michigan · Michigan Medicine · U-M Rogel Cancer Center
10 papers on CoChatORCID 0000-0002-3130-2533
Most cited papers
- Verified
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 5,151
- Verified
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature
Ferroptosis and cancer prognosisCancer Immunotherapy and Biomarkers
Cited by 2,880
- Verified
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell
Gut microbiota and healthOral microbiology and periodontitis research
Cited by 2,198
- Verified
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature
Cancer Immunotherapy and BiomarkersEpigenetics and DNA Methylation
Cited by 1,201
- Verified
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 748
- Verified
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 733
- Verified
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Zhao, E., Maj, T., Kryczek, I., Li, W., Wu, K., Zhao, L., Wei, S., Crespo, J., Wan, S., Vatan, L., et al. (2016) · Nature Immunology
Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism
Cited by 405
- Verified
Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research
Cancer Immunotherapy and BiomarkersImmune cells in cancer
Cited by 380
- Verified
Human T H 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 278
- Verified
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy
Cancer Immunotherapy and BiomarkersCytokine Signaling Pathways and Interactions
Cited by 138
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free